Brad Rees

Chairman at G2 Therapies Pty Ltd.

Finance

Health Technology

Commercial Services

Profile

Brad Rees is currently the Chairman at G2 Therapies Pty Ltd.
He previously worked as a Managing Director at Goldman Sachs & Partners (Australia) Pty Ltd.
in 2007 and as a Director at The Garvan Institute of Medical Research.

Brad Rees active positions

Companies	Position	Start
G2 Therapies Pty Ltd. G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia.	Chairman	-

All active positions of Brad Rees

Former positions of Brad Rees

Companies	Position	End
Goldman Sachs & Partners (Australia) Pty Ltd.	President	2006-12-31
The Garvan Institute of Medical Research The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia.	Director/Board Member	-

See the detail of Brad Rees's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brad Rees's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Goldman Sachs & Partners (Australia) Pty Ltd.	Finance
G2 Therapies Pty Ltd. G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia.	Health Technology
The Garvan Institute of Medical Research The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia.	Commercial Services

See company connections